Tocilizumab Antibody
Tocilizumab is a humanized monoclonal antibody that neutralizes the interleukin-6 receptor (IL-6R), inhibiting both classical and trans IL-6 signaling pathways. It is a critical research tool for studying inflammatory diseases like rheumatoid arthritis and has been investigated in clinical research for severe COVID-19 cytokine storm.
Product Specifications
Product Name Alternative
Tocilizumab, respiratory failure, rheumatoid, Inhibitor, Interleukin Related, Interleukin, IL-6R, inhibit, Neutralizing, arthritis, Anti-Human IL6R, Humanized Antibody, antibody, dyspnoea, COVID-19, coronavirus disease
Target
Interleukin
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
21.5 mg/mL
Purity
98.00% (May vary between batches)
Molecular Weight
145.2 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1880080-01 0.01 mg
Human HCAR2 full length protein-synthetic nanodisc
Sign In for Pricing
View Details MBS1880080-02 0.05 mg
Human HCAR2 full length protein-synthetic nanodisc
Sign In for Pricing
View Details MBS1880080-03 0.1 mg
Human HCAR2 full length protein-synthetic nanodisc
Sign In for Pricing
View Details 
043596-ML490 100 µL
ULK1, phosphorylated (S317) (ULK1, KIAA0722, Serine/threonine-protein kinase ULK1, Autophagy-related protein 1 homolog, Unc-51-like kinase 1) (MaxLight 490) discontinued
Sign In for Pricing
View Details 